Results 171 to 180 of about 3,035 (215)

The Heartline Experience: Achieving Long-Term Participant Engagement in Digital Health Technology Trials. [PDF]

open access: yesJACC Adv
Nikolovski J   +16 more
europepmc   +1 more source

Impact of daratumumab refractoriness on clinical outcomes following CAR T-cell therapy for relapsed refractory multiple myeloma. [PDF]

open access: yesBlood Cancer J
Sebastian T   +22 more
europepmc   +1 more source

A study to learn how well enfortumab vedotin (EV) with pembrolizumab works and how safe it is in people with advanced urothelial cancer: a plain language summary of the EV-302/KEYNOTE-A39 study. [PDF]

open access: yesFuture Oncol
Powles T   +23 more
europepmc   +1 more source

Artificial intelligence for algorithmic trading digital assets: evidence from the Counter-Strike 2 skin market. [PDF]

open access: yesFront Artif Intell
Guede-Fernández F   +6 more
europepmc   +1 more source

Reporting of primary endpoint and associated spin in randomized myeloma trials. [PDF]

open access: yesOncologist
Singstock M   +5 more
europepmc   +1 more source

Forecasting Trends in Androgen Deprivation Therapy Intensification for Metastatic Hormone-Sensitive Prostate Cancer: A Retrospective Population-Based Cohort and Time-Series Analysis. [PDF]

open access: yesCurr Oncol
Khosh Kish E   +18 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy